チモロールマレイン酸塩
Based on 6 publication(s) in Google Scholar
(S)-Timolol Maleate (L-714,465 Maleate) is a non-cardioselective hydrophilic β-adrenoceptor blocker. (S)-Timolol Maleate is widely used as standard medication for intraocular pressure (glaucoma) by preventing the production of aqueous humor. (S)-Timolol Maleate can be used for hypertension, angina pectoris and myocardial infarction.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.77%
- CAS 番号: 26921-17-5
- 分子式: C17H28N4O7S
- 分子量:432.49
-
保管条件:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
MedChemExpress(MCE)の使用を引用している文献 (S)-Timolol maleate
More-
In Vivo Efficacy Study
-
Cell Imaging/Staining
-
In Vivo Efficacy Study
-
Cell Imaging/Staining
-
Cell Proliferation/Viability Assay
Adrenergic Receptor アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
|
β adrenergic receptor |
体外実験
Timolol maleate represents a chiral compound with one asymmetric carbon in its structure. Single isomer, (S)-enantiomer, is a non-cardioselective β-adrenergic blocker. Its commonest application is in topical treatment of increasing intraocular pressure in patients with chronic open angle glaucoma and also in aphakic patients[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 26921-17-5
-
性状 Solid
-
分子量 432.49
-
分子式 C17H28N4O7S
-
Color White to off-white
-
SMILES
O[C@H](COC1=NSN=C1N2CCOCC2)CNC(C)(C)C.O=C(O)/C=C\C(O)=O
-
別名
(S)-Timolol (maleate); (S)-L-714,465 (maleate); MK 950
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (6)
-
Journal Impact Factor
-
Most Recent
-
Adv Mater
Colloid-Forming Prodrug-Hydrogel Composite Prolongs Lower Intraocular Pressure in Rodent Eyes after Subconjunctival Injection. [Abstract]2025 Feb;37(8):e2419306. PMID: 39763100
(S)-Timolol maleate purchased from MedChemExpress. Usage Cited in: Adv Mater. 2025 Feb;37(8):e2419306. [Abstract]
Live-cell percentages were assessed by calcein-AM and Hoechst staining in hTCEpi cells after treatment with Timolol maleate ((S)-Timolol Maleate; 0.137% w/v; 24 h). The Timolol maleate group showed a significantly lower percentage of live cells.
(S)-Timolol maleate purchased from MedChemExpress. Usage Cited in: Adv Mater. 2025 Feb;37(8):e2419306. [Abstract]
IOP was monitored over 24 h and 56 d in rats after a single subconjunctival injection of soluble Timolol maleate ((S)-Timolol Maleate; 0.137% w/v, 30 μL). Timolol maleate significantly reduced IOP at 6 h, but the effect was no longer significant at 24 h.
-
(S)-Timolol maleate purchased from MedChemExpress. Usage Cited in: Adv Funct Mater. 2026 Jun 11.
IOP was monitored in New Zealand white rabbits after a single subconjunctival injection of (S)-timolol maleate solution or DSGS-T (DSGS loaded with (S)-timolol maleate) (Timolol maleate; both 1 mg/mL, 0.1 mL per eye; single dose). Timolol maleate and DSGS-T significantly decreased IOP compared with saline.
-
Protein Cell
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy. [Abstract]2019 Mar;10(3):178-195. PMID: 29542010
(S)-Timolol maleate purchased from MedChemExpress. Usage Cited in: Protein Cell. 2019 Mar;10(3):178-195. [Abstract]
Cell viability was assessed in Huh7.5.1 cells after treatment with (S)-timolol maleate ((S)-timolol; 10 μM; 48 h) and expressed relative to 0.5% DMSO-treated control cells.
-
Redox Biol
2025 Feb:79:103481. PMID: 39721495 -
Mater Today Bio
Transdermal delivery of timolol maleate using hydrogel microneedles for the treatment of infantile haemangiomas. [Abstract]2025 Apr 12:32:101752. PMID: 40290897
(S)-Timolol maleate purchased from MedChemExpress. Usage Cited in: Mater Today Bio. 2025 Apr 12:32:101752. [Abstract]
Live-dead cell staining demonstrates the effects of different timolol maleate ((S)-Timolol maleate,TIM; 600-1500 μM; 24 h) concentrations on the cell morphology of 3D-cultured HemECs. Compared to control group, TIM-treated HemECs showed the disappearance of filopodia, exhibited a rounded shape, and had a significant reduction in cell count.
(S)-Timolol maleate purchased from MedChemExpress. Usage Cited in: Mater Today Bio. 2025 Apr 12:32:101752. [Abstract]
Cell viability was assessed by CCK-8 in 3D-cultured HemECs after treatment with Timolol maleate ((S)-Timolol maleate,TIM; 600-1500 μM; 24 h) and in 2D-cultured HemECs after treatment with TIM (10-10000 mM; 24 or 48 h). TIM inhibited HemEC growth in a concentration-dependent manner.
(S)-Timolol maleate purchased from MedChemExpress. Usage Cited in: Mater Today Bio. 2025 Apr 12:32:101752. [Abstract]
Hemangioma appearance and volume were evaluated in mouse with haemangiomas and tumour grafts after treatment for 2 weeks with Free TIM ((S)-Timolol maleate; 0.5%, 40 μL/cm²; topical administration; three times daily) or BSAMA-TIM-MNs (9 mg/mL; transdermal microneedles; replaced every 3 d). BSAMA-TIM-MNs controlled hemangioma volume more effectively than Free TIM or blank microneedles and produced a decreasing trend in hemangioma size.
(S)-Timolol maleate purchased from MedChemExpress. Usage Cited in: Mater Today Bio. 2025 Apr 12:32:101752. [Abstract]
H&E staining of hemangiomas from mouse with haemangiomas and tumour grafts after treatment for 2 weeks with Free TIM ((S)-Timolol maleate; 0.5%, 40 μL/cm²; topical administration; three times daily) or BSAMA-TIM-MNs (9 mg/mL; transdermal microneedles; replaced every 3 d). H & E staining of the haemangioma tissue revealed a reduced number of microvessels in the BSAMA-TIM-MNs group compared to those in the other three groups.
(S)-Timolol maleate purchased from MedChemExpress. Usage Cited in: Mater Today Bio. 2025 Apr 12:32:101752. [Abstract]
GLUT-1 immunofluorescence staining and fluorescence intensity in mouse with haemangiomas and tumour grafts after treatment for 2 weeks with Free TIM ((S)-Timolol maleate; 0.5%, 40 μL/cm²; topical administration; three times daily) or BSAMA-TIM-MNs (9 mg/mL; transdermal microneedles; replaced every 3 d). The fluorescence intensity of GLUT-1 was weaker after treatment with BSAMA-TIM-MNs than in the other three groups.
(S)-Timolol maleate purchased from MedChemExpress. Usage Cited in: Mater Today Bio. 2025 Apr 12:32:101752. [Abstract]
GLUT-1 expression was examined by western blotting in mouse with haemangiomas and tumour grafts after treatment for 2 weeks with Free TIM ((S)-Timolol maleate; 0.5%, 40 μL/cm²; topical administration; three times daily) or BSAMA-TIM-MNs (9 mg/mL; transdermal microneedles; replaced every 3 d). GLUT-1 expression was reduced by treatment with BSAMA-TIM-MNs and Free TIM.
-
溶剤 & 溶解度
体外:
DMSO : 100 mg/mL (231.22 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : 50 mg/mL (115.61 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
体内:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (5.78 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (5.78 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 20 mg/mL (46.24 mM); Clear solution; Need ultrasonic and warming and heat to 60°C
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
純度とドキュメンテーション
-
データシート (282 KB)
-
SDS (557 KB)
- English - EN (557 KB)
- Français - FR (557 KB)
- Deutsch - DE (557 KB)
- Norwegian - NO (557 KB)
- Español - ES (557 KB)
- Swedish - SV (557 KB)
- Italian - IT (557 KB)
- Korean - KR (557 KB)
- Portuguese - PT (557 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Mitrović M, et al. Analytical quality by design development of an ecologically acceptable enantioselective HPLC method for timolol maleate enantiomeric purity testing on ovomucoid chiral stationary phase. J Pharm Biomed Anal. 2020 Feb 20;180:113034. [Content Brief]
[2]. Wedian F, et al. Simultaneous spectrofluorometric analysis of tablets containing hydrochlorothiazide combined with timolol maleate or amiloride hydrochloride. Acta Pharm. 2020 Sep 1;70(3):373-385. [Content Brief]
[3]. Sun L, et al. Fractional 2940-nm Er:YAG Laser-Assisted Drug Delivery of Timolol Maleate for the Treatment of Deep Infantile Hemangioma. J Dermatolog Treat. 2020 Feb 11:1-24. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O / DMSO | 1 mM | 2.3122 mL | 11.5610 mL | 23.1219 mL | 57.8048 mL |
| 5 mM | 0.4624 mL | 2.3122 mL | 4.6244 mL | 11.5610 mL | |
| 10 mM | 0.2312 mL | 1.1561 mL | 2.3122 mL | 5.7805 mL | |
| 15 mM | 0.1541 mL | 0.7707 mL | 1.5415 mL | 3.8537 mL | |
| 20 mM | 0.1156 mL | 0.5780 mL | 1.1561 mL | 2.8902 mL | |
| 25 mM | 0.0925 mL | 0.4624 mL | 0.9249 mL | 2.3122 mL | |
| 30 mM | 0.0771 mL | 0.3854 mL | 0.7707 mL | 1.9268 mL | |
| 40 mM | 0.0578 mL | 0.2890 mL | 0.5780 mL | 1.4451 mL | |
| 50 mM | 0.0462 mL | 0.2312 mL | 0.4624 mL | 1.1561 mL | |
| 60 mM | 0.0385 mL | 0.1927 mL | 0.3854 mL | 0.9634 mL | |
| 80 mM | 0.0289 mL | 0.1445 mL | 0.2890 mL | 0.7226 mL | |
| 100 mM | 0.0231 mL | 0.1156 mL | 0.2312 mL | 0.5780 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.